Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 15, 2007

Pfizer Animal Health Gains Access to Crucell’s PER.C6

  • Crucell and Pfizer Animal Health signed  a research license agreement for PER.C6®. The deal allows Pfizer Animal Health to use the cell technology in the production of a undisclosed veterinary vaccine.

    Pfizer Animal Health has an option to convert the research license into a commercial agreement.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »